Interactive Session - Legal Professional Interest Group and the Society of Reproductive Biologists and Technologists - Laboratory and Clinical Errors
Date:October 22,
2012
Time:1:15 pm - 2:15 pm
Location:Room 4 - San Diego Convention Center
Presenters
Jacob F. Mayer, Jr., Ph.D. (Chair), Jones Institute for Reproductive Medicine
Susan L. Crockin, J.D., Crockin Law & Policy Group
C. Brent Barrett, Ph.D., Boston IVF Laboratory
Laboratory and Clinical Errors: Real Life Pitfalls and How to Avoid Them
Needs Assessment and Description
Assisted reproductive technology (ART) laboratories
and laboratory personnel need to be watchful and
knowledgeable about their obligations and vulnerabilities.
This live interactive session will be of value not only to
laboratory directors and personnel, but also medical
directors, risk managers and attorneys who are involved in
ART laboratory management. Given both the proliferation
in embryo and gamete freezing, and the growing types
of families utilizing various ART treatments, laboratory
professionals must recognize the potential pitfalls and
establish safeguards for their practices.
Learning Objectives
At the conclusion of this session, participants should be able
to:
- Enumerate legal uncertainties and potential safeguards,
particularly for genetic material involving gamete donors,
non-traditional couples, single intended parents and
embryo donation.
- Identify the critical elements in creating a laboratory
environment that minimizes mistakes.
- Discuss the importance of selecting, training and working
with embryologists so that they are less likely to make a
mistake.
- Describe how to use protocols and laboratory structure to
minimize mistakes.
ACGME Competency
Professionalism
TEST QUESTION:
Long-time patients of your ART program have now moved
on to embryo donation by locating 6 embryos from an
outside broker, which considers this “embryo adoption.” The
patients ask your program to accept the shipped embryos,
implant them two at a time, and store any remaining
embryos while they are in treatment or become pregnant.
The embryos were originally created with donor eggs and
donated by a same-sex couple. After participating in this
session, in my practice I will:
- Reject the embryos on the basis that this violates the
U.S. Food and Drug Administration/American Society for
Reproductive Medicine testing and/or storage
requirements.
- Review any legal agreement(s) between the patients
and the donors and matching program before
accepting the embryos or agreeing to treat.
- Accept the embryos on a limited basis, with additional
documentation restricting/outlining the practice’s
obligations as to parentage and long-term storage (and
other potential restrictions).
- Not applicable to my area of practice.